92 related articles for article (PubMed ID: 20842653)
21. Hemolytic Uremic Syndrome After an Escherichia coli O111 Outbreak.
Piercefield EW; Bradley KK; Coffman RL; Mallonee SM
Arch Intern Med; 2010 Oct; 170(18):1656-63. PubMed ID: 20937925
[TBL] [Abstract][Full Text] [Related]
22. [Hemolytic uremic syndrome associated with entero-hemorrhagic Escherichia coli].
Takeda T
Nihon Rinsho; 1993 Jan; 51(1):198-203. PubMed ID: 8433519
[TBL] [Abstract][Full Text] [Related]
23. The protective ability of the Mediterranean plant extracts against the oxidative DNA damage. The role of the radical oxygen species and the polyphenol content.
Kapiszewska M; Sołtys E; Visioli F; Cierniak A; Zajac G
J Physiol Pharmacol; 2005 Mar; 56 Suppl 1():183-97. PubMed ID: 15800394
[TBL] [Abstract][Full Text] [Related]
24. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.
Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J
Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress and membrane fluidity in erythrocytes from patients with hemolytic uremic syndrome.
Facorro G; Aguirre F; Florentin L; Díaz M; De Paoli T; Ihlo JE; Hager AA; Sánchez Avalos JC; Farach HA; Poole CP
Acta Physiol Pharmacol Ther Latinoam; 1997; 47(3):137-46. PubMed ID: 9339243
[TBL] [Abstract][Full Text] [Related]
26. Unusual amount of (-)-mesquitol from the heartwood of Prosopis juliflora.
Sirmah P; Dumarçay S; Masson E; Gérardin P
Nat Prod Res; 2009; 23(2):183-9. PubMed ID: 19173126
[TBL] [Abstract][Full Text] [Related]
27. Role of Non-O157:H7 Escherichia coli in hemolytic uremic syndrome.
Goldwater PN; Bettelheim KA
Clin Infect Dis; 2002 Aug; 35(3):346-7. PubMed ID: 12115108
[No Abstract] [Full Text] [Related]
28. A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome.
Cimolai N; Basalyga S; Mah DG; Morrison BJ; Carter JE
Clin Nephrol; 1994 Aug; 42(2):85-9. PubMed ID: 7955583
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and protective effects of coumarin derivatives against oxidative stress induced by doxorubicin.
Beillerot A; Domínguez JC; Kirsch G; Bagrel D
Bioorg Med Chem Lett; 2008 Feb; 18(3):1102-5. PubMed ID: 18164200
[TBL] [Abstract][Full Text] [Related]
30. [Hemolytic uremic syndrome in children of Mendoza, Argentina: association with Shiga toxin-producing Escherichia coli infection].
Rivas M; Balbi L; Miliwebsky ES; García B; Tous MI; Leardini NA; Prieto MA; Chillemi GM; de Principi ME
Medicina (B Aires); 1998; 58(1):1-7. PubMed ID: 9674201
[TBL] [Abstract][Full Text] [Related]
31. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome.
Arbus GS
Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954
[TBL] [Abstract][Full Text] [Related]
32. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.
Frank C; Werber D; Cramer JP; Askar M; Faber M; an der Heiden M; Bernard H; Fruth A; Prager R; Spode A; Wadl M; Zoufaly A; Jordan S; Kemper MJ; Follin P; Müller L; King LA; Rosner B; Buchholz U; Stark K; Krause G;
N Engl J Med; 2011 Nov; 365(19):1771-80. PubMed ID: 21696328
[TBL] [Abstract][Full Text] [Related]
33. [Hemorrhagic colitis and hemolytic-uremic syndrome--E. coli as the etiologic agent. I. Bacteriology and pathogenesis].
Tschäpe H; Böhme G
Kinderarztl Prax; 1991 Jun; 59(6):161-5. PubMed ID: 1921166
[TBL] [Abstract][Full Text] [Related]
34. Fruits are rich in antioxidants and ripe for topical therapy.
Sivamani RK; Maibach HI
J Dermatolog Treat; 2009; 20(4):186-9. PubMed ID: 19296346
[TBL] [Abstract][Full Text] [Related]
35. [Effect of tea polyphenols on oxidative metabolism of polymorphonuclear neutrophils in healthy and obese people].
Zielińska-Przyjemska M; Dobrowolska-Zachwieja A
Pol Merkur Lekarski; 2005 Jul; 19(109):41-7. PubMed ID: 16194025
[TBL] [Abstract][Full Text] [Related]
36. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.
Masri C; Proulx F; Toledano B; Clermont MJ; Mariscalco MM; Seidman EG; Carcillo J
Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669
[TBL] [Abstract][Full Text] [Related]
37. Antioxidant activity of inflorescences, leaves and fruits of three Sorbus species in relation to their polyphenolic composition.
Olszewska MA; Michel P
Nat Prod Res; 2009; 23(16):1507-21. PubMed ID: 19844825
[TBL] [Abstract][Full Text] [Related]
38. Protective effect of Zizyphus lotus jujube fruits against cypermethrin-induced oxidative stress and neurotoxicity in mice.
Abdelhafidh K; Mhadhbi L; Mezni A; Badreddine S; Beyrem H; Mahmoudi E
Biomarkers; 2018 Mar; 23(2):167-173. PubMed ID: 29017403
[TBL] [Abstract][Full Text] [Related]
39. Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera.
Watarai S; Yokota K; Tana ; Kishimoto T; Kanadani T; Taketa K; Oguma K
J Clin Microbiol; 2001 Feb; 39(2):798-800. PubMed ID: 11158156
[TBL] [Abstract][Full Text] [Related]
40. Plasma exchange therapy for the treatment of Escherichia coli O-157 associated hemolytic uremic syndrome.
Nakatani T; Tsuchida K; Yoshimura R; Sugimura K; Takemoto Y
Int J Mol Med; 2002 Nov; 10(5):585-8. PubMed ID: 12373296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
